22nd Century PE Ratio 2012-2026 | XXII

Current and historical p/e ratio for 22nd Century (XXII) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. 22nd Century PE ratio as of September 16, 2026 is 0.00.

Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
22nd Century PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2026-09-16 1.72 0.00
2026-06-30 4.05 $18,635.65 0.00
2026-03-31 44.20 $15,349.60 0.00
2025-12-31 231.00 $-1,057.40 0.00
2025-09-30 507.00 $2,494,637.39 0.00
2025-06-30 2259.00 $1,966,907.25 0.00
2025-03-31 9936.00 $1,792,270.30 0.01
2024-12-31 36639.00 $-914,221.10 0.00
2024-09-30 200272.00 $-113,208,501.10 0.00
2024-06-30 694899.00 $-112,680,747.75 0.00
2024-03-31 1000000.00 $-112,502,744.56 0.00
2023-12-31 1000000.00 $-109,779,506.05 0.00
2023-09-30 1000000.00 $-108.76 0.00
2023-06-30 1000000.00 $-48.95 0.00
2023-03-31 1000000.00 $-26.09 0.00
2022-12-31 1000000.00 $-4.65 0.00
2022-09-30 1000000.00 $-2.03 0.00
2022-06-30 1000000.00 $-1.15 0.00
2022-03-31 1000000.00 $-0.23 0.00
2021-12-31 1000000.00 $-0.21 0.00
2021-09-30 1000000.00 $-0.16 0.00
2021-06-30 1000000.00 $-0.13 0.00
2021-03-31 1000000.00 $-0.14 0.00
2020-12-31 1000000.00 $-0.14 0.00
2020-09-30 1000000.00 $-0.15 0.00
2020-06-30 1000000.00 $-0.20 0.00
2020-03-31 1000000.00 $-0.22 0.00
2019-12-31 1000000.00 $-0.21 0.00
2019-09-30 1000000.00 $-0.22 0.00
2019-06-30 1000000.00 $-0.10 0.00
2019-03-31 1000000.00 $-0.09 0.00
2018-12-31 1000000.00 $-0.06 0.00
2018-09-30 1000000.00 $-0.03 0.00
2018-06-30 1000000.00 $-0.10 0.00
2018-03-31 1000000.00 $-0.09 0.00
2017-12-31 1000000.00 $-0.13 0.00
2017-09-30 1000000.00 $-0.14 0.00
2017-06-30 1000000.00 $-0.14 0.00
2017-03-31 1000000.00 $-0.14 0.00
2016-12-31 1000000.00 $-0.15 0.00
2016-09-30 1000000.00 $-0.15 0.00
2016-06-30 1000000.00 $-0.16 0.00
2016-03-31 1000000.00 $-0.14 0.00
2015-12-31 1000000.00 $-0.16 0.00
2015-09-30 1000000.00 $-0.21 0.00
2015-06-30 1000000.00 $-0.22 0.00
2015-03-31 1000000.00 $-0.23 0.00
2014-12-31 1000000.00 $-0.26 0.00
2014-09-30 1000000.00 $-0.37 0.00
2014-06-30 1000000.00 $-0.64 0.00
2014-03-31 1000000.00 $-0.62 0.00
2013-12-31 1000000.00 $-0.60 0.00
2013-09-30 1000000.00 $-0.53 0.00
2013-06-30 1000000.00 $-0.22 0.00
2013-03-31 1000000.00 $-0.21 0.00
2012-12-31 1000000.00 $-0.22 0.00
2012-09-30 1000000.00 $-0.05 0.00
2012-06-30 1000000.00 $-0.06 0.00
2012-03-31 1000000.00 $-0.10 0.00
2011-12-31 1000000.00 $-0.05 0.00
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.001B $0.018B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $302.542B 23.96
Altria (MO) United States $116.565B 12.58
British American Tobacco (BTI) United Kingdom $114.738B 0.00
JAPAN TOB (JAPAY) Japan $77.655B 24.03
Imperial Tobacco Group (IMBBY) United Kingdom $25.912B 0.00
Turning Point Brands (TPB) United States $1.356B 30.05
Universal (UVV) United States $1.104B 21.42
Air Global (AIIR) United States $0.288B 0.00
Ispire Technology (ISPR) United States $0.083B 0.00